Lung nodule detection and potential impact on guideline-based management: a retrospective post-market evaluation of three commercial software systems - Report - MDSpire
Advertisement
Lung nodule detection and potential impact on guideline-based management: a retrospective post-market evaluation of three commercial software systems
Clinical Report: Evaluation of Lung Nodule Identification and Its Influence
Overview
This study evaluates the performance of three commercial AI software tools in detecting lung nodules. The findings indicate variability in the number of actionable nodules identified.
Background
Lung nodules are common findings in CT imaging, with significant implications for lung cancer management. The increasing use of AI tools for nodule detection presents a means to improve diagnostic accuracy and efficiency.
Data Highlights
No numerical data or trial results were provided in the source material.
Key Findings
Three AI software tools were evaluated for lung nodule detection: AI-Rad Companion, contextflow ADVANCE, and Veolity LungCAD.
The study focused on nodules between 5 mm and 3 cm in diameter, reviewed by experienced radiologists.
Actionable nodules were defined based on the British Thoracic Society criteria.
Variability in the number of detected actionable nodules was observed across different software tools.
The study did not compare human versus AI sensitivity, as AI results were not blinded.
Clinical Implications
The variability in actionable nodule detection among different AI tools suggests that clinicians should be aware of the specific software used in their practice.
Conclusion
The study evaluates AI tools for lung nodule detection and their implications for clinical management.
by Anna Jöbstl, Anna K. Luger, Bernhard Nilica, Florian Kocher, Thomas Sonnweber, Ivan Tancevski, Florian Augustin, Laurenz Nagl, Daniel Leitner, Gerlig Widmann
